Quick Answer
OptimizeRx Corp reported Operating Income of $11.69 million for fiscal year 2025.
OptimizeRx Corp Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $11.69M | +185.3% |
| 2024 | -$13.71M | +48.1% |
| 2023 | -$26.40M | -114.8% |
| 2022 | -$12.29M | -3503.7% |
| 2021 | $361.1K | +116.9% |
| 2020 | -$2.14M | +42.2% |
| 2019 | -$3.69M | -2150.5% |
| 2018 | $180.1K | +108.5% |
| 2017 | -$2.13M | -34.7% |
| 2016 | -$1.58M | -164.7% |
| 2015 | -$597.4K | +41.8% |
| 2014 | -$1.03M | -283.6% |
| 2013 | -$267.5K | +41.2% |
| 2012 | -$454.9K | +68.7% |
| 2011 | -$1.45M | +21.2% |
| 2010 | -$1.85M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.05M | +123.9% | -35.7% |
| June 30, 2025 | $3.19M | +185.1% | +250.9% |
| March 31, 2025 | -$2.11M | +58.0% | +75.3% |
| September 30, 2024 | -$8.56M | -141.0% | -128.4% |
| June 30, 2024 | -$3.75M | +22.7% | +25.5% |
| March 31, 2024 | -$5.03M | +28.8% | -41.5% |
| September 30, 2023 | -$3.55M | +5.4% | +26.7% |
| June 30, 2023 | -$4.85M | -24.1% | +31.3% |
- OptimizeRx Corp showed an increase of +185.3% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, OptimizeRx Corp’s operating income has grown by 733.3% (from -$1.85 million to $11.69 million).
- The most recent figure is from OptimizeRx Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: